Skip to main content
. Author manuscript; available in PMC: 2022 Feb 16.
Published in final edited form as: Circulation. 2021 Jan 27;143(7):661–672. doi: 10.1161/CIRCULATIONAHA.120.051558

Table 2.

Adverse events by sex (ablation)

Male Patients Receiving Ablation (n = 633) Female Patients Receiving Ablation (n = 373)
Event n (%)* n (%)*
Catheter Insertion
 Hematoma 13 (2.1) 9 (2.4)
 Pseudo aneurysm 6 (0.9) 5 (1.3)
 Atrial venous fistula 3 (0.5) 1 (0.3)
 Pneumothorax - -
 Sepsis 1 (0.2) -
 DVT - -
 Pulmonary embolus - -
Ablation-related Events
 Severe pericardial chest pain 9 (1.4) 2 (0.5)
 Esophageal ulcer 1 (0.2) 4 (1.1)
 Left inferior Pulmonary Vein Stenosis > 75% 1 (0.2) -
 Phrenic nerve injury - 1 (0.3)
 Atrial esophageal fistula - -
Catheter Manipulation Within the Heart
 TIA 2 (0.3) 1 (0.3)
 Myocardial infarction - 1 (0.3)
 Cardiac tamponade with perforation - -
 Complete heart block - -
 Coronary occlusion - -
 Valvular damage - -
Medication-related Events
 Heparin induced bleeding - -
*

n (%) = number (percent) of patients who reported ablation-related adverse event. Percent is calculated among patients who have received ablation.